Remove Clinical Research Remove Pharma Companies Remove Small Molecule
article thumbnail

Where is the drug discovery expertise happening in the UK?

Drug Discovery World

This environment of research excellence, in turn, fosters R&D, innovation, spin-offs, start-ups, networking, collaboration and entrepreneurship, which sets a sturdy foundation that attracts funding, and creates an appealing work culture.

Drugs 189
article thumbnail

Top 10 Drug Discovery Trends at the Top 20 Pharma

PerkinElmer

By a 3:1 margin, PerkinElmer found top Pharma screens for a specific target. Small molecules are making a comeback. These simple, stable compounds, used to treat various conditions, are the focus for 78% of preclinical research. Pharma companies must improve productivity and efficiency amidst rising R&D costs.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

BioSpace Movers & Shakers, Dec. 18

The Pharma Data

Cadavid will be responsible for the strategy, direction and execution of the company’s clinical development programs. Prior to Fulcrum, Cadavid held several leadership positions at Biogen, including Senior Medical Director of the multiple sclerosis clinical development group. AB2 Bio – Swiss pharma company AB2 Bio Ltd.

article thumbnail

Rethinking the pharma R&D lifecycle with AI in mind

Drug Discovery World

The rest of the pharma R&D system — how drugs are developed, tested, approved, and manufactured — will need to accommodate this vast increase in speed and scale. Pharma R&D has been heading in the wrong direction, becoming progressively less efficient over the last few decades.

article thumbnail

New horizon for cancer innovation

Drug Discovery World

TH : Increasingly, large pharma companies need scale, agility and access to academic partnerships to succeed. This funding is distributed between funding discovery research at our core institutes, and at universities around the UK, clinical research, cancer grand challenges, and translational research. .

article thumbnail

BioSpace Global Roundup, Oct. 15

The Pharma Data

The new services have been developed to support pre-clinical research by optimizing hiPSC-derived cell culture, while providing high-quality electrophysiological data acquisition and analysis from physiologically relevant human cell models. Axol Bioscience – Based in the U.K., Dolmatics – U.K.-based based Dotmatics Ltd.